269 related articles for article (PubMed ID: 29907137)
1. Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer.
Kanda R; Hiraike H; Wada-Hiraike O; Ichinose T; Nagasaka K; Sasajima Y; Ryo E; Fujii T; Osuga Y; Ayabe T
BMC Cancer; 2018 Jun; 18(1):657. PubMed ID: 29907137
[TBL] [Abstract][Full Text] [Related]
2. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.
Yang S; Lin C; Zhuo X; Wang J; Rao S; Xu W; Cheng Y; Yang L
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1019-E1030. PubMed ID: 32985256
[TBL] [Abstract][Full Text] [Related]
5. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.
Li XN; Bu HM; Ma XH; Lu S; Zhao S; Cui YL; Sun J
Exp Clin Endocrinol Diabetes; 2017 Feb; 125(2):91-97. PubMed ID: 28008585
[No Abstract] [Full Text] [Related]
7. Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway.
Liu ZZ; Duan XX; Yuan MC; Yu J; Hu X; Han X; Lan L; Liu BW; Wang Y; Qin JF
Life Sci; 2022 Apr; 294():120370. PubMed ID: 35124000
[TBL] [Abstract][Full Text] [Related]
8. Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells.
Zhao HJ; Jiang X; Hu LJ; Yang L; Deng LD; Wang YP; Ren ZP
J Mol Endocrinol; 2020 Feb; 64(2):103-113. PubMed ID: 31855560
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways.
Wu YC; Wang WT; Lee SS; Kuo YR; Wang YC; Yen SJ; Lee MY; Yeh JL
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336911
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide alleviates H
Ma X; Lin W; Lin Z; Hao M; Gao X; Zhang Y; Kuang H
Peptides; 2017 Jun; 92():1-8. PubMed ID: 28450048
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
[TBL] [Abstract][Full Text] [Related]
13. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
Zhao H; Wei R; Wang L; Tian Q; Tao M; Ke J; Liu Y; Hou W; Zhang L; Yang J; Hong T
Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1431-41. PubMed ID: 24801389
[TBL] [Abstract][Full Text] [Related]
14. Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer.
Cases AI; Ohtsuka T; Kimura H; Zheng B; Shindo K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Oncol Rep; 2015 Oct; 34(4):1717-25. PubMed ID: 26238361
[TBL] [Abstract][Full Text] [Related]
15. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
Zhang L; Zhang L; Li Y; Li L; Melchiorsen JU; Rosenkilde M; Hölscher C
J Parkinsons Dis; 2020; 10(2):523-542. PubMed ID: 31958096
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells.
Zhao X; Liu G; Shen H; Gao B; Li X; Fu J; Zhou J; Ji Q
Int J Mol Med; 2015 Mar; 35(3):684-92. PubMed ID: 25573030
[TBL] [Abstract][Full Text] [Related]
17. Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.
Shigeoka T; Nomiyama T; Kawanami T; Hamaguchi Y; Horikawa T; Tanaka T; Irie S; Motonaga R; Hamanoue N; Tanabe M; Nabeshima K; Tanaka M; Yanase T; Kawanami D
J Diabetes Investig; 2020 Sep; 11(5):1137-1149. PubMed ID: 32146725
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes.
Nagae K; Uchi H; Morino-Koga S; Tanaka Y; Oda M; Furue M
Diabetes Res Clin Pract; 2018 Dec; 146():155-161. PubMed ID: 30367901
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy.
Wen Y; Wu K; Xie Y; Dan W; Zhan Y; Shi Q
Biochem Biophys Res Commun; 2019 Mar; 511(1):79-86. PubMed ID: 30770099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
